DeepMed Research

JNJ-17299425

Generic Name: JNJ-17299425

Clinical Trials

An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain Injury

Phase 2

Terminated

Conditions: Traumatic Brain Injury

Interventions: Drug: JNJ-17299425

First Posted Date: 2013-03-20

Last Posted Date: 2013-05-01

Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Target Recruit Count: 7

Registration Number: NCT01814982

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy